BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21899971)

  • 21. ¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.
    Cheng X; Bao L; Xu Z; Li D; Wang J; Li Y
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):136-42. PubMed ID: 22498184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for detecting bladder lesions? A meta-analysis of the literature.
    Wang N; Jiang P; Lu Y
    Urol Int; 2014; 92(2):143-9. PubMed ID: 23941766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY; Lin CL; Kao CH
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.
    Apolo AB; Riches J; Schöder H; Akin O; Trout A; Milowsky MI; Bajorin DF
    J Clin Oncol; 2010 Sep; 28(25):3973-8. PubMed ID: 20679618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.
    Treglia G; Salsano M; Stefanelli A; Mattoli MV; Giordano A; Bonomo L
    Skeletal Radiol; 2012 Mar; 41(3):249-56. PubMed ID: 22072239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: a systematic review and meta-analysis.
    Lu YY; Chen JH; Liang JA; Chu S; Lin WY; Kao CH
    Nucl Med Commun; 2014 Jul; 35(7):697-703. PubMed ID: 24694775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S, Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam Hospital, Amsterdam, The Netherlands.: BJU Int 2013; 112(6):72934. doi:10.1111/bju.12109. [Epub 2013 Jun 24].
    See WA
    Urol Oncol; 2014 Nov; 32(8):1350. PubMed ID: 25488385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT.
    Lu YY; Chen JH; Ding HJ; Chien CR; Lin WY; Kao CH
    Nucl Med Commun; 2012 Nov; 33(11):1127-33. PubMed ID: 23000829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Chang MC; Chen JH; Liang JA; Yang KT; Cheng KY; Kao CH
    Eur J Radiol; 2013 Feb; 82(2):366-73. PubMed ID: 23083522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Evaluation of 18F-FDG PET/CT Imaging in Recurrent or Residual Urinary Bladder Cancer: A Meta-Analysis.
    Xue M; Liu L; Du G; Fu Z
    Urol J; 2020 Apr; 17(6):562-567. PubMed ID: 32309863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.
    Lu YY; Chen JH; Chien CR; Chen WT; Tsai SC; Lin WY; Kao CH
    Int J Colorectal Dis; 2013 Aug; 28(8):1039-47. PubMed ID: 23407908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.
    Wang HY; Ding HJ; Chen JH; Chao CH; Lu YY; Lin WY; Kao CH
    Cancer Imaging; 2012 Oct; 12(3):464-74. PubMed ID: 23108238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
    Chang MC; Chen JH; Liang JA; Lin CC; Yang KT; Cheng KY; Yeh JJ; Kao CH
    Acad Radiol; 2012 Mar; 19(3):349-57. PubMed ID: 22173321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of [(18)F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer.
    Jiang J; Yang Z; Zhang Y; Xu X; Wang M; Hu S; Yao Z; Pan H; Zhang Y; Li D
    Clin Imaging; 2014; 38(6):797-801. PubMed ID: 24973077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.
    Mertens LS; Mir MC; Scott AM; Lee ST; Fioole-Bruining A; Vegt E; Vogel WV; Manecksha R; Bolton D; Davis ID; Horenblas S; van Rhijn BW; Lawrentschuk N
    Urology; 2014 Feb; 83(2):393-8. PubMed ID: 24468513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Yield of Body CT and Whole-Body FDG PET/CT for Initial Systemic Staging in Patients With Suspected Primary CNS Lymphoma: A Systematic Review and Meta-Analysis.
    Park HY; Suh CH; Huang RY; Guenette JP; Kim HS
    AJR Am J Roentgenol; 2021 May; 216(5):1172-1182. PubMed ID: 32812800
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.
    Annunziata S; Pizzuto DA; Caldarella C; Galiandro F; Sadeghi R; Treglia G
    World J Gastroenterol; 2015 Oct; 21(40):11481-8. PubMed ID: 26523112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
    Rouanne M; Girma A; Neuzillet Y; Vilain D; Radulescu C; Letang N; Yonneau L; Hervé JM; Botto H; Le Stanc E; Lebret T
    Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
    Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ
    Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.